SUNNYVALE, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Scios Inc.
(Nasdaq: SCIO) plans to announce its fourth quarter and full year 2001 results
on Thursday, February 7, 2002, in a press release that will be issued at
approximately
9:00 a.m., EST. The press release will also be available on the Company's Web
site, http://www.sciosinc.com.
A conference call to discuss these financial results will be held at
10:00 a.m. EST. Investors may participate via live webcast at
http://www.sciosinc.com.
To access the conference call, dial 800-364-4174 (domestic) /
706-634-5159 (international) with passcode 2870735. For those unable to
listen to the live events, the webcast will be archived for 15 business days
following the event. A replay of the conference call will be available by
dialing 800-642-1687 (domestic) / 706-645-9291 (international) with passcode
2870735 beginning approximately 2 hours after the event and last through
February 14, 2002.
Scios Inc.
Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease. The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.
SOURCE Scios Inc.
 back to top
Related links:
http://www.sciosinc.com
CONTACT:
Wendy Carhart of Scios Inc., +1-408-616-8325;
or Jim Weiss of WeissCom Partners, Inc., +1-415-203-0328, for
Scios Inc.
|
